The Human Genome Project has set the
stage for countless
advancements in our understanding of human DNA and its role
in the diagnosis
of disease. Nowhere is this more true than in the area of women’s
health. Pathologists and clinicians are increasingly turning to the power
of molecular genetics for early and accurate diagnoses of disease.
New testing methods are creating
opportunities to screen for common disorders affecting women, such
as Human papillomavirus (HPV),
Chlamydia Trachomatis (CT), Neisseria gonorrhea (NG),
Cystic Fibrosis (CF) and Inherited Thrombophilia (IHT). These innovations
offer pathologists
and clinicians
the ability to add molecular diagnostics
to
their laboratories.
|
